应用扩散张量成像评估接受大剂量顺式维甲酸治疗的高危神经母细胞瘤儿童幸存者的生长障碍
前瞻性研究对20例接受大剂量顺式维甲酸治疗的高危神经母细胞瘤幸存者及20名年龄性别匹配对照行股骨远端骺板3.0T扩散张量成像,幸存者各向异性分数、归一化纤维束体积和纤维束浓度均显著低于对照(P<0.01),且与身高Z评分相关;对生长激素治疗有反应者上述参数高于无反应者。
要点
- 高危神经母细胞瘤幸存者股骨远端骺板DTI参数显著低于健康对照,提示骺板异常。
- DTI参数与身高Z评分线性相关(R2>0.31,P<0.001),可反映矮身材程度。
- 对生长激素治疗有反应者FA和纤维束浓度更高,纤维束成像上纤维束丰富。
核心结论
- DTI可显示高危神经母细胞瘤幸存者的骺板异常,该异常与矮身材相关,并能反映对生长激素治疗的反应。
研究设计与样本
- 前瞻性研究,纳入20例接受大剂量顺式维甲酸治疗的高危神经母细胞瘤幸存者(平均年龄12.4岁,7例女性)及20名年龄性别匹配对照,行股骨远端骺板及邻近干骺端3.0T扩散张量成像。
关键影像表现/征象
- 幸存者股骨远端骺板DTI参数显著低于对照(P<0.01),尤其在接受顺式维甲酸和全身照射者中(P<0.05)。
- 纤维束成像上,对生长激素无反应者纤维束几乎缺失,有反应者纤维束丰富(P=0.02)。
诊断标准与关键数值
- 纤维束浓度(tracts/cm2):幸存者23.2±14.7 vs 对照36.7±10.5。
- 归一化纤维束体积(cm3/cm2):幸存者0.44±0.27 vs 对照0.70±0.21。
- 各向异性分数(FA):幸存者0.22±0.05 vs 对照0.26±0.02。
- 生长激素有反应者FA 0.25±0.04 vs 无反应者0.18±0.03(P=0.02);纤维束浓度31.4±13.7 vs 14.8±7.9 tracts/cm2(P<0.05)。
- FA、归一化纤维束体积和纤维束浓度与身高Z评分线性相关(R2>0.31;P<0.001)。
临床应用与阅片要点
- 股骨远端骺板DTI参数(FA、归一化纤维束体积、纤维束浓度)可用于评估高危神经母细胞瘤幸存者的骺板异常。
- 纤维束成像上纤维束几乎缺失可能提示对生长激素治疗无反应,纤维束丰富可能提示有反应。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: The survival of patients with high-risk neuroblastoma has increased with multimodal therapy, but most survivors demonstrate growth failure.
OBJECTIVE: To assess physeal abnormalities in children with high-risk neuroblastoma in comparison to normal controls by using diffusion tensor imaging (DTI) of the distal femoral physis and adjacent metaphysis.
MATERIALS AND METHODS: We prospectively obtained physeal DTI at 3.0 T in 20 subjects (mean age: 12.4 years, 7 females) with high-risk neuroblastoma treated with high-dose cis-retinoic acid, and 20 age- and gender-matched controls. We compared fractional anisotropy (FA), normalized tract volume (cm3/cm2) and tract concentration (tracts/cm2) between the groups, in relation to height Z-score and response to growth hormone therapy. Tractography images were evaluated qualitatively.
RESULTS: DTI parameters were significantly lower in high-risk neuroblastoma survivors compared to controls (P<0.01), particularly if the patients were exposed to both cis-retinoic acid and total body irradiation (P<0.05). For survivors and controls, DTI values were respectively [mean ± standard deviation]: tract concentration (tracts/cm2), 23.2±14.7 and 36.7±10.5; normalized tract volume (cm3/cm2), 0.44±0.27 and 0.70±0.21, and FA, 0.22±0.05 and 0.26±0.02. High-risk neuroblastoma survivors responding to growth hormone compared to non-responders had higher FA (0.25±0.04 and 0.18±0.03, respectively, P=0.02), and tract concentration (tracts/cm2) (31.4±13.7 and 14.8±7.9, respectively, P<0.05). FA, normalized tract volume and tract concentration were linearly related to height Z-score (R2>0.31; P<0.001). Qualitatively, tracts were nearly absent in all non-responders to growth hormone and abundant in all responders (P=0.02).
CONCLUSION: DTI shows physeal abnormalities that correlate with short stature in high-risk neuroblastoma survivors and demonstrates response to growth hormone treatment.
引用
- Delgado J, Jaramillo D, Chauvin NA, et al. Evaluating growth failure with diffusion tensor imaging in pediatric survivors of high-risk neuroblastoma treated with high-dose cis-retinoic acid. Pediatr Radiol. 2019. PMID: 31055614. doi:10.1007/s00247-019-04409-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。